Stephen R Spellman Selected Research

Stem Cell Transplantation

12/2020	Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.
10/2020	Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study.
1/2017	Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
5/2013	Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.
5/2011	One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen R Spellman Research Topics

Disease

40	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 11/2010
24	Leukemia 12/2023 - 11/2010
16	Neoplasms (Cancer) 01/2024 - 08/2003
14	Hematologic Neoplasms (Hematological Malignancy) 05/2024 - 11/2010
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 11/2010
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2024 - 11/2010
8	Bronchiolitis Obliterans Syndrome 10/2023 - 02/2015
8	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 02/2015
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 04/2009
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 11/2010
4	Infections 10/2020 - 08/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 01/2016
2	Asymptomatic Infections 08/2023 - 10/2022
2	COVID-19 08/2023 - 01/2021
2	Lymphoma (Lymphomas) 01/2023 - 01/2018
2	Brain Neoplasms (Brain Tumor) 01/2004 - 08/2003
1	Primary Myelofibrosis (Myelosclerosis) 12/2023
1	Pathologic Complete Response 12/2023
1	Bone Marrow Failure Disorders 12/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Juvenile Myelomonocytic Leukemia 11/2021
1	Dysbiosis 01/2021
1	Febrile Neutropenia 01/2021
1	Cytopenia 12/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Inflammation (Inflammations) 12/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Genomic Instability 07/2017
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2016
1	HIV Infections (HIV Infection) 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015
1	Hematologic Diseases (Blood Diseases) 03/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2007
1	Glioma (Gliomas) 01/2004

Drug/Important Bio-Agent (IBA)

9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 01/2020
6	HLA-A Antigens (HLA-A)IBA 01/2020 - 04/2009
5	KIR ReceptorsIBA 12/2023 - 11/2013
5	HLA Antigens (Human Leukocyte Antigens)IBA 08/2023 - 11/2010
5	AntigensIBA 01/2019 - 05/2011
4	HLA-B Antigens (HLA-B)IBA 08/2023 - 10/2016
4	HLA-DPB1 antigen (HLA DPB1)IBA 01/2022 - 01/2020
3	Calcineurin InhibitorsIBA 01/2024 - 01/2019
3	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 01/2020
3	Minor Histocompatibility AntigensIBA 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 07/2017
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 10/2015
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 10/2015
3	CytokinesIBA 01/2019 - 01/2004
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 10/2015
2	phytobacteriomycin (PBM)IBA 03/2024 - 01/2023
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2024 - 01/2019
2	LigandsIBA 11/2021 - 01/2021
2	Peptides (Polypeptides)IBA 01/2021 - 11/2013
2	HLA-DP Antigens (HLA-DP)IBA 01/2020 - 08/2015
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 01/2019
2	HLA-C Antigens (HLA-C)IBA 12/2014 - 02/2014
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2007 - 01/2004
1	tert-butylserineIBA 12/2023
1	HLA-DQ Antigens (HLA-DQ)IBA 01/2022
1	Isoantigens (Alloantigen)IBA 10/2021
1	CXC ChemokinesIBA 01/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Penicillins (Penicillin)FDA Link 01/2021
1	Interferon Type IIBA 12/2019
1	Alemtuzumab (Campath)FDA Link 01/2019
1	AdiponectinIBA 01/2019
1	LeptinIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	AdipokinesIBA 01/2019
1	Amino Acids FDA Link 01/2018
1	NucleotidesIBA 07/2017
1	Proteins (Proteins, Gene)FDA Link 07/2017
1	micaIBA 03/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2016
1	ABO Blood-Group SystemIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 07/2012
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2012
1	Tyrosine Kinase InhibitorsIBA 07/2012
1	Cancer VaccinesIBA 08/2007
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2004
1	Interleukin-2 (IL2)IBA 01/2004
1	Interleukin-12 (IL 12)IBA 01/2004

Therapy/Procedure

55	Cell Transplantation 05/2024 - 08/2010
29	Transplantation 03/2024 - 11/2010
10	Therapeutics 12/2020 - 08/2007
8	Hematopoietic Stem Cell Transplantation 02/2024 - 05/2011
5	Stem Cell Transplantation 12/2020 - 05/2011
5	Homologous Transplantation 01/2020 - 02/2015
2	Donor Selection 01/2019 - 01/2018
1	Consolidation Chemotherapy 01/2020
1	Autologous Transplantation 01/2018
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2010
1	Infusion Pumps (Infusion Pump) 08/2007
1	Immunotherapy 01/2004